PGR and neoplasm: In general, the two scales identified similar predictors of more severe skin toxicity, including higher BMI, more advance tumor stage and invasive ductal histology, progesterone receptor (PR) negative status, conventionally fractionated regimens with RT dose to whole breast ≥45 Gy, the use of a lumpectomy cavity boost, and above‐median breast volume.